SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications

Acta Physiol (Oxf). 2021 Apr;231(4):e13608. doi: 10.1111/apha.13608. Epub 2021 Jan 7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Animals
  • COVID-19 / pathology*
  • Cardiovascular Diseases / drug therapy*
  • Humans
  • Mice
  • Renin-Angiotensin System / physiology*
  • SARS-CoV-2*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors